We first knocked down these five USPs separately in the three PCa cell lines, and found that several candidates (USP14, USP22, and USP26) were shown to be able to regulate AR/ARv7 expression and reverse ABT263 effects (Figure 5B–D). The gene discussed is USP14; the disease is posterior cortical atrophy.